Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.02 – $0.75
21% from low
Exchange
OTC Link
OS
Borrow rate
17.13%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.6M | $2.9M | $6.1M | $6.1M | $4.2M | $4.3M | $7.1M |
| Cost of revenue | $1.7M | $2.3M | $5.3M | $8.4M | $5.9M | $4.9M | $6.1M |
| Gross profit | −$29.2K | $565.0K | $753.1K | −$2.3M | −$1.7M | $1.3M | $973.8K |
| Gross margin | -1.8% | 19.8% | 12.4% | -38.6% | -41.5% | 30.3% | 13.8% |
| R&D | $34.4K | $41.1K | $155.6K | $201.0K | $278.9K | $66.3K | $62.0K |
| Operating income | −$212.4K | −$477.5K | −$5.8M | −$6.0M | −$3.7M | −$2.2M | −$476.1K |
| EBITDA | −$197.7K | −$433.2K | −$5.5M | −$5.6M | −$3.0M | −$986.5K | −$955.5K |
| Net income | −$217.2K | −$542.0K | −$6.7M | −$6.6M | −$4.5M | −$1.6M | −$1.6M |
| Net margin | -13.2% | -19.0% | -110.4% | -109.7% | -109.0% | -37.3% | -23.2% |
| EPS (diluted) | -0.01 | -0.02 | -0.19 | -0.14 | -0.07 | -0.02 | -0.01 |
Annual figures · source: Financial Modeling Prep
NEPRA FOODS INC
No one on the platform currently holds NPRFF.
No tracked institution reports a position in NPRFF as of their last filing.
No one on the platform has traded NPRFF yet.
| $3M |
| — |
| HNFSAHanover Foods Corporation | $48.50 | -3.00% | $14M | — |
| INBPIntegrated BioPharma, Inc. | $0.18 | +0.00% | $6M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 2.1× sales vs its 1.6× historical median P/S.
Fair value ≈ $0.13 · price $0.17 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.